Clinical Outcome of Lipiflow Treatment Prior to Cataract Surgery in Dry Eye Patients

Samsung Medical Center

Status: Unknown

Conditions: Dry Eye

Treatments: Device: Lipiflow Thermal pulsation

Study type: Interventional

Funder types: Other

Identifiers

NCT04457999

2019-03-011

Details and patient eligibility

About

To investigate the clinical outcome of Lipiflow treatment prior to cataract surgery in patients with meibomian gland dysfunction and dry eye disease

Enrollment: 100 estimated patients

Sex: All

Ages: 21+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients older than 21, who will get catarct surgeyr
• Patients whose visual acuity anticipated better than 20/25 after surgery
• Patients with informed consent
• Patients with meibomian gland dysfunction

Exclusion criteria

• ocular injury, active injection
• uncontrolled systemic disease
• Contact lens wear within 1 month
• Allergic to fluorescein sodium or topical anesthetics
• ocular surgery or trauma within 6 months
• disorder of lid anatomy
• other reason for decreased vision other than cataract
• anticipated visual acuity less than 20/25
• Patients less than 20 years.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

Lipiflow treatment

Experimental group

Description:

Lipiflow thermal pulsation prior to cataract surgery

Treatment:

Device: Lipiflow Thermal pulsation